TGCT

Clinical trials for TGCT explained in plain language.

Never miss a new study

Get alerted when new TGCT trials appear

Sign up with your email to follow new studies for TGCT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug could shrink rare joint tumors without surgery

Disease control Ongoing

This study tests an investigational drug called emactuzumab for people with a rare joint tumor (TGCT) that can't be removed surgically. About 128 participants will receive either the drug or a placebo to see if it shrinks tumors and improves joint function. The goal is to offer a…

Matched conditions: TGCT

Phase: PHASE3 • Sponsor: SynOx Therapeutics Limited • Aim: Disease control

Last updated Jun 27, 2026 09:01 UTC

TGCT

Get alerted when new TGCT trials appear

New drug could shrink rare joint tumors without surgery